iScience· Cheng·收录于· 13 小时前
Survival after neoadjuvant versus adjuvant chemotherapy in operable hormone receptor-positive HER2-negative breast cancer
Survival after neoadjuvant versus adjuvant chemotherapy in operable hormone receptor-positive HER2-negative breast cancer
来源:iScience · doi.org